AstraZeneca pauses COVID-19 vaccine trial, shares slip on rollout doubts

The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange in New York, on Apr 8, 2019. LONDON: AstraZeneca's suspension of global trials of its experimental coronavirus vaccine after an unexplained illness in a study subject in Britain has cast doubt on prospects for an early rollout.

The vaccine, which Britain's AstraZeneca is developing with the University of Oxford, has been described by the World Health Organization as probably the world's leading candidate and the furthest developed.AstraZeneca said on Tuesday it had paused trials, including late-stage ones, to allow an independent committee to review safety data, and it was working to minimise any potential impact on the timeline.

"It is obviously a challenge to this particular vaccine trial," Britain's Health Secretary Matt Hancock told Sky News. The patient was suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis, said Chief Executive Pascal Soriot, according to Stat News, citing investors who had listened to a call it said was organised by JPMorgan.The diagnosis has yet to be confirmed, but the patient is recovering and will likely be discharged from the hospital soon, the CEO reportedly added.

The pause follows reports that the United States was aiming for fast-track authorisation or approval before November's presidential election.

Source: Law Daily Report (lawdailyreport.net)

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AstraZeneca suspends leading COVID-19 vaccine trials after a participant's illnessThe vaccine, developed with the University of Oxford, has been described by the World Health Organization as probably the world's leading candidate and the most advanced in terms of development. The suspension dims prospects for an early rollout amid reports that the United States was aiming for
Source: YahooSG - 🏆 3. / 71 Read more »

AstraZeneca puts Covid-19 vaccine trial on hold over safety concern: ReportWASHINGTON/LONDON (REUTERS) - AstraZeneca Plc has put a hold on the late-stage trial of its highly-anticipated Covid-19 vaccine candidate after a suspected serious adverse reaction in a study participant, health news website Stat News reported on Tuesday (Sept 8).. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

AstraZeneca puts COVID-19 vaccine trial on hold over safety concern: ReportAstraZeneca Plc has put a hold on the late-stage trial of its highly-anticipated COVID-19 vaccine candidate after a suspected serious adverse ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

AstraZeneca pauses Covid-19 vaccine trial after unexplained illnessWASHINGTON — Pharmaceutical company AstraZeneca said Tuesday (Sept 8) it had
Source: TODAYonline - 🏆 1. / 99 Read more »

Australia not worried about Covid-19 vaccine trial pause, cases rise in VictoriaSYDNEY (REUTERS) - Australia is not worried about a report that a Covid-19 vaccine trial has been put on hold due to suspected serious adverse reaction, its deputy chief medical officer said on Wednesday (Sept 9), as daily cases nudged higher in the country's coronavirus hot spot.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Australia not worried about COVID-19 vaccine trial pause, cases rise in hot spotAustralia's coronavirus hot spot of Victoria state on Wednesday reported 76 new cases and 11 deaths from the virus in the last 24 hours.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »